Expertise in
3
conditions

Michael Karremann

Mannheim, BW, DE 
Expertise in
3
conditions
Mannheim, BW, DE 

Overview

Michael Karremann practices practicing medicine in Mannheim, Germany.

Mr. Karremann is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Gliomatosis Cerebri, and Brain Tumor.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Mannheim, BW, Germany
Other Locations
Bonn, NW, Germany
Jena, TH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3

33 Total Publications

Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?
Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?
Journal: Neuro-oncology advances
Published: February 12, 2026

Frequently Asked Questions about Michael Karremann

Is Michael Karremann a top-rated expert for Diffuse Midline Glioma H3 K27M-Mutant?

MediFind is an objective health platform that identifies experts based on real-world data. Michael Karremann is classified as an Advanced expert for Diffuse Midline Glioma H3 K27M-Mutant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael Karremann participate in research or clinical trials?

Yes. Michael Karremann has published 33 articles and abstracts on conditions like Diffuse Midline Glioma H3 K27M-Mutant. You can view a list of Michael Karremann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Karremann's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile